Lucas Arraes de França
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucas Arraes de França has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Danilo Bora Moleta
Hospital viValle
6 shared publications - Marcelo Luiz Campos Vieira
Heart Institute (Incor), São Paulo University Medical School, São Paulo, Brazil, Brazil
4 shared publications - Cassio Carvalho Soeiro Machado
Hospital do Coração do Brasil
2 shared publications - Denise Tessariol Hachul
Universidade de São Paulo, Brasil
2 shared publications - Edgar Daminello
Hospital Israelita Albert Einstein
2 shared publications - Fanny Wulkan
Laboratory of Genetics and Molecular Cardiology, Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo 05403-900, Brazil
2 shared publications
Latest Publications
- Open Access
- 3 February 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 38 (4)
O que o Trabalho Miocárdico Oferece a Mais que o Strain?
- 3 February 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 38 (4)
Open AccessO que o Trabalho Miocárdico Oferece a Mais que o Strain?
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 38 (4)
What Does Myocardial Work Offer Beyond Strain?
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 38 (4)
What Does Myocardial Work Offer Beyond Strain?
- Open Access
- 30 August 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (3)
Como Eu Faço a Fração de Ejeção do Ventrículo Esquerdo: Do Bidimensional ao Tridimensional
A ecocardiografia é o método diagnóstico mais usado para aferição de índices de função sistólica do ventrículo esquerdo (VE), permitindo a estimativa rápida, disponível e não invasiva de parâmetros como volumes ventriculares, stroke volume e fração de ejeção. O conhecimento detalhado da técnica é muito importante para estimativa acurada dessas medidas. Também é importante seu refinamento, intimamente associado à experiência do examinador e ao conhecimento dos softwares atuais. Neste artigo de revisão, será discutido como medir com precisão os volumes do VE e sua fração de ejeção usando técnicas ecocardiográficas bidimensionais e tridimensionais, com dicas e sugestões baseadas nas principais diretrizes de quantificação de câmaras cardíacas americanas e europeias, bem como nos artigos mais recentes da literatura.
- 30 August 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (3)
Open AccessComo Eu Faço a Fração de Ejeção do Ventrículo Esquerdo: Do Bidimensional ao Tridimensional
A ecocardiografia é o método diagnóstico mais usado para aferição de índices de função sistólica do ventrículo esquerdo (VE), permitindo a estimativa rápida, disponível e não invasiva de parâmetros como volumes ventriculares, stroke volume e fração de ejeção. O conhecimento detalhado da técnica é muito importante para estimativa acurada dessas medidas. Também é importante seu refinamento, intimamente associado à experiência do examinador e ao conhecimento dos softwares atuais. Neste artigo de revisão, será discutido como medir com precisão os volumes do VE e sua fração de ejeção usando técnicas ecocardiográficas bidimensionais e tridimensionais, com dicas e sugestões baseadas nas principais diretrizes de quantificação de câmaras cardíacas americanas e europeias, bem como nos artigos mais recentes da literatura.
- Open Access
- 29 August 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (3)
My Approach to Calculate the Left Ventricular Ejection Fraction: From a Two-Dimensional to a Three-Dimensional Technique
Echocardiography is the most used diagnostic method for measuring left ventricular systolic function indices. It is possible to estimate, in a
- 29 August 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (3)
Open AccessMy Approach to Calculate the Left Ventricular Ejection Fraction: From a Two-Dimensional to a Three-Dimensional Technique
Echocardiography is the most used diagnostic method for measuring left ventricular systolic function indices. It is possible to estimate, in a
- Open Access
- 27 August 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (3)
My Approach To Echocardiographic Evaluation in Arrhythmogenic Cardiomyopathy
Careful echocardiographic evaluation of the right ventricle, although challenging and sometimes neglected, is of utmost importance in the
- 27 August 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (3)
Open AccessMy Approach To Echocardiographic Evaluation in Arrhythmogenic Cardiomyopathy
Careful echocardiographic evaluation of the right ventricle, although challenging and sometimes neglected, is of utmost importance in the
- Open Access
- 1 August 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (3)
Como Eu Faço a Avaliação Ecocardiográfica na Cardiomiopatia Arritmogênica
A avaliação ecocardiográfica criteriosa do ventrículo direito (VD), embora desafiadora e por vezes negligenciada, é de fundamental importância no diagnóstico de determinadas patologias, tais como a cardiomiopatia arritmogênica (CMA) – doença miocárdica hereditária associada ao desenvolvimento de arritmias ventriculares, insuficiência cardíaca e morte súbita. Este artigo tem o objetivo de revisar os critérios diagnósticos propostos na Task Force de 2010 e as modificações sugeridas pelos critérios de Pádua de 2020, além de ilustrar o uso potencial de técnicas avançadas de ecocardiografia para detecção mais precoce e definição prognóstica.
- 1 August 2024
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 37 (3)
Open AccessComo Eu Faço a Avaliação Ecocardiográfica na Cardiomiopatia Arritmogênica
A avaliação ecocardiográfica criteriosa do ventrículo direito (VD), embora desafiadora e por vezes negligenciada, é de fundamental importância no diagnóstico de determinadas patologias, tais como a cardiomiopatia arritmogênica (CMA) – doença miocárdica hereditária associada ao desenvolvimento de arritmias ventriculares, insuficiência cardíaca e morte súbita. Este artigo tem o objetivo de revisar os critérios diagnósticos propostos na Task Force de 2010 e as modificações sugeridas pelos critérios de Pádua de 2020, além de ilustrar o uso potencial de técnicas avançadas de ecocardiografia para detecção mais precoce e definição prognóstica.
- Open Access
- 9 January 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (2) , 150
Enhancing Arrhythmogenic Right Ventricular Cardiomyopathy Detection and Risk Stratification: Insights from Advanced Echocardiographic Techniques
Introduction: The echocardiographic diagnosis criteria for arrhythmogenic right ventricular cardiomyopathy (ARVC) are highly specific but sensitivity is low, especially in the early stages of the disease. The role of echocardiographic strain in ARVC has not been fully elucidated, although prior studies suggest that it can improve the detection of subtle functional abnormalities. The purposes of the study were to determine whether these advanced measures of right ventricular (RV) dysfunction on echocardiogram, including RV strain, increase diagnostic value for ARVC disease detection and to evaluate the association of echocardiographic parameters with arrhythmic outcomes. Methods: The study included 28 patients from the Heart Institute of São Paulo ARVC cohort with a definite diagnosis of ARVC established according to the 2010 Task Force Criteria. All patients were submitted to ECHO’s advanced techniques including RV strain, and the parameters were compared to prior conventional visual ECHO and CMR. Results: In total, 28 patients were enrolled in order to perform ECHO’s advanced techniques. A total of 2/28 (7%) patients died due to a cardiovascular cause, 2/28 (7%) underwent heart transplantation, and 14/28 (50%) patients developed sustained ventricular arrhythmic events. Among ECHO’s parameters, RV dilatation, measured by RVDd (p = 0.018) and RVOT PSAX (p = 0.044), was significantly associated with arrhythmic outcomes. RV free wall longitudinal strain < 14.35% in absolute value was associated with arrhythmic outcomes (p = 0.033). Conclusion: Our data suggest that ECHO’s advanced techniques improve ARVC detection and that abnormal RV strain can be associated with arrhythmic risk stratification. Further studies are necessary to better demonstrate these findings and contribute to risk stratification in ARVC, in addition to other well-known risk markers.
- 9 January 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (2) , 150
Open AccessEnhancing Arrhythmogenic Right Ventricular Cardiomyopathy Detection and Risk Stratification: Insights from Advanced Echocardiographic Techniques
Introduction: The echocardiographic diagnosis criteria for arrhythmogenic right ventricular cardiomyopathy (ARVC) are highly specific but sensitivity is low, especially in the early stages of the disease. The role of echocardiographic strain in ARVC has not been fully elucidated, although prior studies suggest that it can improve the detection of subtle functional abnormalities. The purposes of the study were to determine whether these advanced measures of right ventricular (RV) dysfunction on echocardiogram, including RV strain, increase diagnostic value for ARVC disease detection and to evaluate the association of echocardiographic parameters with arrhythmic outcomes. Methods: The study included 28 patients from the Heart Institute of São Paulo ARVC cohort with a definite diagnosis of ARVC established according to the 2010 Task Force Criteria. All patients were submitted to ECHO’s advanced techniques including RV strain, and the parameters were compared to prior conventional visual ECHO and CMR. Results: In total, 28 patients were enrolled in order to perform ECHO’s advanced techniques. A total of 2/28 (7%) patients died due to a cardiovascular cause, 2/28 (7%) underwent heart transplantation, and 14/28 (50%) patients developed sustained ventricular arrhythmic events. Among ECHO’s parameters, RV dilatation, measured by RVDd (p = 0.018) and RVOT PSAX (p = 0.044), was significantly associated with arrhythmic outcomes. RV free wall longitudinal strain < 14.35% in absolute value was associated with arrhythmic outcomes (p = 0.033). Conclusion: Our data suggest that ECHO’s advanced techniques improve ARVC detection and that abnormal RV strain can be associated with arrhythmic risk stratification. Further studies are necessary to better demonstrate these findings and contribute to risk stratification in ARVC, in addition to other well-known risk markers.
- Open Access
- 6 March 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 36 (1)
My Approach to Right Ventricular Longitudinal Strain with Automated 2D and 3D Software
Introduction The assessment of right ventricular (RV) systolic function has long been neglected. In recent years, there has been a great leap in the
- 6 March 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 36 (1)
Open AccessMy Approach to Right Ventricular Longitudinal Strain with Automated 2D and 3D Software
Introduction The assessment of right ventricular (RV) systolic function has long been neglected. In recent years, there has been a great leap in the
- 1 February 2023
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (2) , 86-95
Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort
Background:Arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disease, causes ventricular tachycardia, sudden cardiac death, and heart failure (HF). We investigated ARVC clinical features, genetic findings, natural history, and the occurrence of life-threatening arrhythmic events (LTAEs), HF death, or heart transplantation (HF-death/HTx) to identify risk factors. Methods:The clinical course of 111 consecutive patients with definite ARVC, predictors of LTAE, HF-death/HTx, and combined events were analyzed in the entire cohort and in a subgroup of 40 patients without sustained ventricular arrhythmia before diagnosis. Results:The 5-year cumulative probability of LTAE was 30% and HF-death/HTx was 10%. Predictors of HF-death/HTx were reduced right ventricle ejection fraction (HR: 0.93; P=0.010), HF symptoms (HR: 4.37; P=0.010), epsilon wave (HR: 4.99; P=0.015), and number of leads with low QRS voltage (HR: 1.28; P=0.001). Each additional lead with low QRS voltage increased the risk of HF-death/HTx by 28%. Predictors of LTAE were prior syncope (HR: 1.81; P=0.040), number of leads with T wave inversion (HR: 1.17; P=0.039), low QRS voltage (HR: 1.12; P=0.021), younger age (HR: 0.97; P=0.006), and prior ventricular arrhythmia/ventricular fibrillation (HR: 2.45; P=0.012). Each additional lead with low QRS voltage increased the risk of LTAE by 17%. In patients without ventricular arrhythmia before clinical diagnosis of ARVC, the number of leads with low QRS voltage (HR: 1.68; P=0.023) was independently associated with HF-death/HTx. Conclusions:Our study demonstrated the characteristics of a specific cohort with a high prevalence of arrhythmic burden at presentation, male predominance, younger age and HF severe outcomes. Our main results suggest that the presence and extension of low QRS voltage can be a risk predictor for HF-death/HTx in ARVC patients, regardless of the arrhythmic risk. This study can contribute to the global ARVC risk stratification, adding new insights to the international current scientific knowledge.
- 1 February 2023
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (2) , 86-95
Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort
Background:Arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disease, causes ventricular tachycardia, sudden cardiac death, and heart failure (HF). We investigated ARVC clinical features, genetic findings, natural history, and the occurrence of life-threatening arrhythmic events (LTAEs), HF death, or heart transplantation (HF-death/HTx) to identify risk factors. Methods:The clinical course of 111 consecutive patients with definite ARVC, predictors of LTAE, HF-death/HTx, and combined events were analyzed in the entire cohort and in a subgroup of 40 patients without sustained ventricular arrhythmia before diagnosis. Results:The 5-year cumulative probability of LTAE was 30% and HF-death/HTx was 10%. Predictors of HF-death/HTx were reduced right ventricle ejection fraction (HR: 0.93; P=0.010), HF symptoms (HR: 4.37; P=0.010), epsilon wave (HR: 4.99; P=0.015), and number of leads with low QRS voltage (HR: 1.28; P=0.001). Each additional lead with low QRS voltage increased the risk of HF-death/HTx by 28%. Predictors of LTAE were prior syncope (HR: 1.81; P=0.040), number of leads with T wave inversion (HR: 1.17; P=0.039), low QRS voltage (HR: 1.12; P=0.021), younger age (HR: 0.97; P=0.006), and prior ventricular arrhythmia/ventricular fibrillation (HR: 2.45; P=0.012). Each additional lead with low QRS voltage increased the risk of LTAE by 17%. In patients without ventricular arrhythmia before clinical diagnosis of ARVC, the number of leads with low QRS voltage (HR: 1.68; P=0.023) was independently associated with HF-death/HTx. Conclusions:Our study demonstrated the characteristics of a specific cohort with a high prevalence of arrhythmic burden at presentation, male predominance, younger age and HF severe outcomes. Our main results suggest that the presence and extension of low QRS voltage can be a risk predictor for HF-death/HTx in ARVC patients, regardless of the arrhythmic risk. This study can contribute to the global ARVC risk stratification, adding new insights to the international current scientific knowledge.